Avanos Medical Inc (AVNS)
Gross profit margin
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Gross profit | US$ in thousands | 381,300 | 379,700 | 450,000 | 364,300 | 373,300 |
Revenue | US$ in thousands | 687,800 | 673,300 | 820,000 | 744,600 | 714,800 |
Gross profit margin | 55.44% | 56.39% | 54.88% | 48.93% | 52.22% |
December 31, 2024 calculation
Gross profit margin = Gross profit ÷ Revenue
= $381,300K ÷ $687,800K
= 55.44%
Avanos Medical Inc's gross profit margin has shown variability over the past five years. In 2020, the gross profit margin was 52.22%, which decreased to 48.93% in 2021. However, there was a positive trend in the following years, with the margin increasing to 54.88% in 2022, 56.39% in 2023, and then slightly decreasing to 55.44% in 2024. Overall, the company has been able to maintain relatively healthy gross profit margins, indicating efficient cost management and pricing strategies during this period.
Peer comparison
Dec 31, 2024
Company name
Symbol
Gross profit margin
Avanos Medical Inc
AVNS
55.44%
Align Technology Inc
ALGN
70.00%
Edwards Lifesciences Corp
EW
79.46%
Intuitive Surgical Inc
ISRG
62.87%
MSA Safety
MSA
47.59%
STERIS plc
STE
43.17%
Zimmer Biomet Holdings Inc
ZBH
17.72%